Intel (NASDAQ:INTC) Health Guide Software Monitoring Health

Intel (NASDAQ:INTC) and General Electric Co. have won FDA approval for Intel
(NASDAQ:INTC) Health Guide. Intel (NASDAQ:INTC) Health Guide Software Monitoring
Health Intel (NASDAQ:INTC)-GE Care Innovations, a joint venture of Intel
(NASDAQ:INTC) and GE, has received U.S. Food and Drug Administration 510(k)
clearance for the Intel (NASDAQ:INTC) Health Guide Express. This is a software
solution that combines in-home monitoring, patient education, and online
provider consultation capabilities to improve chronic disease management. Louis
Burns, the CEO of Intel (NASDAQ:INTC)-GE Care Innovations said that, With this
new platform, Intel-GE Care Innovations facilitates greater care coordination
that gives healthcare organizations the ability to innovate and provide
customized care." Intel Corp. (NASDAQ:INTC) shares are currently standing at
21.79. Price History Last Price: 21.79 52 Week Low / High: 17.6 / 24.37 50 Day
Moving Average: 21.31 6 Month Price Change %: 18.5% 12 Month Price Change %:
3.8%